Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessio Gerussi

Showing results (41-50 of 84) with videos related to

Pageof 9
Sort By:
JHEP Reports : Innovation in Hepatology|April 12, 2026
Paediatric autoimmune liver disease in Europe, the prospective ERN R-Liver registryMikkel Malham, Gema Muñoz Bartolo, Antal Dezsöfi-Gottl, et al.
Hepatology (Baltimore, Md.)|May 14, 2026
Definition, diagnosis, and treatment of primary biliary cholangitis - autoimmune hepatitis (PBC-AIH) variant: An international expert delphi consensusAlessio Gerussi, Marcial Sebode, Eugenia Nofit, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 25, 2018
Association Between Black Race and Presentation and Liver-Related Outcomes of Patients With Autoimmune HepatitisYnto S de Boer, Alessio Gerussi, Floris F van den Brand, et al.
Journal of Personalized Medicine|October 27, 2022
LLM-PBC: Logic Learning Machine-Based Explainable Rules Accurately Stratify the Genetic Risk of Primary Biliary CholangitisAlessio Gerussi, Damiano Verda, Claudio Cappadona, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|March 24, 2026
Artificial Intelligence in hepatology: A position paper by the Italian Association for the Study of the LiverClara Balsano, Anna Alisi, Patrizia Burra, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 6, 2025
Diagnostic Yield of Whole Exome Sequencing in Adult-onset Cholestatic Liver DiseaseMiki Scaravaglio, Luisa Ronzoni, Laura Cristoferi, et al.
The Lancet. Gastroenterology & Hepatology|October 13, 2025
Fatigue in people with primary biliary cholangitis: a position paper from the European Reference Network for Rare Liver DiseasesOzgur M Koc, Anne-Kristin Toussaint, Aurelie Untas, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 30, 2019
Novel biomarkers for primary biliary cholangitis to improve diagnosis and understand underlying regulatory mechanismsMauro Bombaci, Elisa Pesce, Anna Torri, et al.
JHEP Reports : Innovation in Hepatology|October 21, 2022
Role of ductular reaction and ductular-canalicular junctions in identifying severe primary biliary cholangitisDiletta Overi, Guido Carpino, Laura Cristoferi, et al.
BMJ Open|January 9, 2026
Prospective, randomised, placebo-controlled, phase 2 clinical trial assessing the efficacy and safety of oral vancomycin in patients with primary sclerosing cholangitis with/out inflammatory bowel disease in Italy: study protocol of VanC-IT trialLaura Cristoferi, Daphne D'Amato, Cesare Maino, et al.
Pageof 9

Showing results (41-50 of 84) with videos related to

Sort By:
Pageof 9
JHEP Reports : Innovation in Hepatology|April 12, 2026
Paediatric autoimmune liver disease in Europe, the prospective ERN R-Liver registryMikkel Malham, Gema Muñoz Bartolo, Antal Dezsöfi-Gottl, et al.
Hepatology (Baltimore, Md.)|May 14, 2026
Definition, diagnosis, and treatment of primary biliary cholangitis - autoimmune hepatitis (PBC-AIH) variant: An international expert delphi consensusAlessio Gerussi, Marcial Sebode, Eugenia Nofit, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 25, 2018
Association Between Black Race and Presentation and Liver-Related Outcomes of Patients With Autoimmune HepatitisYnto S de Boer, Alessio Gerussi, Floris F van den Brand, et al.
Journal of Personalized Medicine|October 27, 2022
LLM-PBC: Logic Learning Machine-Based Explainable Rules Accurately Stratify the Genetic Risk of Primary Biliary CholangitisAlessio Gerussi, Damiano Verda, Claudio Cappadona, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|March 24, 2026
Artificial Intelligence in hepatology: A position paper by the Italian Association for the Study of the LiverClara Balsano, Anna Alisi, Patrizia Burra, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 6, 2025
Diagnostic Yield of Whole Exome Sequencing in Adult-onset Cholestatic Liver DiseaseMiki Scaravaglio, Luisa Ronzoni, Laura Cristoferi, et al.
The Lancet. Gastroenterology & Hepatology|October 13, 2025
Fatigue in people with primary biliary cholangitis: a position paper from the European Reference Network for Rare Liver DiseasesOzgur M Koc, Anne-Kristin Toussaint, Aurelie Untas, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 30, 2019
Novel biomarkers for primary biliary cholangitis to improve diagnosis and understand underlying regulatory mechanismsMauro Bombaci, Elisa Pesce, Anna Torri, et al.
JHEP Reports : Innovation in Hepatology|October 21, 2022
Role of ductular reaction and ductular-canalicular junctions in identifying severe primary biliary cholangitisDiletta Overi, Guido Carpino, Laura Cristoferi, et al.
BMJ Open|January 9, 2026
Prospective, randomised, placebo-controlled, phase 2 clinical trial assessing the efficacy and safety of oral vancomycin in patients with primary sclerosing cholangitis with/out inflammatory bowel disease in Italy: study protocol of VanC-IT trialLaura Cristoferi, Daphne D'Amato, Cesare Maino, et al.
Pageof 9